Ivan Donev

617 total citations
36 papers, 491 citations indexed

About

Ivan Donev is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ivan Donev has authored 36 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ivan Donev's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Ivan Donev is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Ivan Donev collaborates with scholars based in Bulgaria, Japan and Romania. Ivan Donev's co-authors include Nikolay Conev, Tadaaki Yamada, Wei Wang, Saburo Sone, Kunio Matsumoto, Seiji Yano, Yasuhiko Nishioka, Shinji Takeuchi, Maria Radanova and Takao Yamori and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ivan Donev

35 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Donev Bulgaria 12 250 207 164 132 53 36 491
Andrea Pretta Italy 12 182 0.7× 272 1.3× 102 0.6× 139 1.1× 59 1.1× 47 478
Valerie Odero‐Marah United States 10 334 1.3× 262 1.3× 222 1.4× 139 1.1× 51 1.0× 22 593
Jelena Urosevic Spain 8 221 0.9× 227 1.1× 72 0.4× 111 0.8× 57 1.1× 10 462
Qiong Zhao China 14 145 0.6× 299 1.4× 196 1.2× 82 0.6× 43 0.8× 28 503
Weineng Feng China 13 207 0.8× 347 1.7× 320 2.0× 152 1.2× 63 1.2× 50 646
Kuo-Pao Lai Taiwan 6 227 0.9× 158 0.8× 240 1.5× 95 0.7× 80 1.5× 6 499
Ichiro Nakachi Japan 13 269 1.1× 263 1.3× 374 2.3× 138 1.0× 33 0.6× 34 629
Kaijing Wang China 13 177 0.7× 87 0.4× 134 0.8× 117 0.9× 42 0.8× 35 417
Muhammad Alamgeer Australia 13 294 1.2× 346 1.7× 184 1.1× 176 1.3× 36 0.7× 25 615
Shangce Du China 13 222 0.9× 144 0.7× 106 0.6× 140 1.1× 95 1.8× 14 469

Countries citing papers authored by Ivan Donev

Since Specialization
Citations

This map shows the geographic impact of Ivan Donev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Donev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Donev more than expected).

Fields of papers citing papers by Ivan Donev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Donev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Donev. The network helps show where Ivan Donev may publish in the future.

Co-authorship network of co-authors of Ivan Donev

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Donev. A scholar is included among the top collaborators of Ivan Donev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Donev. Ivan Donev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Conev, Nikolay, et al.. (2022). Impact of travel burden on clinical outcomes in lung cancer. Supportive Care in Cancer. 30(6). 5381–5387. 5 indexed citations
4.
Radanova, Maria, et al.. (2021). New Circulating Circular RNAs with Diagnostic and Prognostic Potential in Advanced Colorectal Cancer. International Journal of Molecular Sciences. 22(24). 13283–13283. 17 indexed citations
5.
Conev, Nikolay, et al.. (2020). 1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them. Annals of Oncology. 31. S1002–S1002. 1 indexed citations
6.
Addeo, Alfredo, Maximilian J. Hochmair, Elizabeth Dudnik, et al.. (2020). 1299P Real-world treatment patterns, clinical outcomes and EGFR/T790M testing practices in patients with EGFRm advanced NSCLC and 1L EGFR TKI therapy: A retrospective multinational study (REFLECT). Annals of Oncology. 31. S840–S840. 1 indexed citations
7.
Conev, Nikolay, et al.. (2020). Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer.. Journal of Clinical Oncology. 38(15_suppl). e21541–e21541. 1 indexed citations
8.
Petrova, Mila, Nikolay Conev, Krassimir Koynov, et al.. (2020). Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer. BioScience Trends. 14(1). 48–55. 47 indexed citations
9.
Conev, Nikolay, et al.. (2020). Fast time estimation is associated with high levels of depression in COPD patients. 115–115. 1 indexed citations
10.
Conev, Nikolay, et al.. (2019). Serum level of miRNA-143 as a potential prognostic marker in patients with colorectal cancer and synchronous metastatic disease. Annals of Oncology. 30. iv81–iv82. 1 indexed citations
11.
Donev, Ivan, et al.. (2019). One-minute time interval estimation as a novel potent indicator of emotional concerns in cancer patients prior to starting chemotherapy. Current Psychology. 40(8). 3997–4003. 2 indexed citations
12.
Tonev, Ivan, et al.. (2019). Fast time estimation to predict levels of anxiety in cancer patients.. Journal of Clinical Oncology. 37(15_suppl). e23162–e23162. 2 indexed citations
13.
Conev, Nikolay, et al.. (2019). RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer. Clinical and investigative medicine. 42(1). E31–E38. 32 indexed citations
14.
Conev, Nikolay, et al.. (2018). One-minute time interval estimation as a novel ultrashort tool for distress screening. Supportive Care in Cancer. 27(6). 2031–2037. 5 indexed citations
15.
Donev, Ivan, et al.. (2018). Quantitative Analysis of Tumor-associated Tissue Eosinophilia in Recurring Bladder Cancer. Cureus. 10(9). e3279–e3279. 11 indexed citations
16.
17.
Radanova, Maria, et al.. (2017). Protective role of S-Adenosylmethionine against fructose-induced oxidative damage in obesity. SHILAP Revista de lepidopterología. 4(2). 163–171. 10 indexed citations
18.
Takeuchi, Shinji, Wei Wang, Qi Li, et al.. (2012). Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer. American Journal Of Pathology. 181(3). 1034–1043. 55 indexed citations
19.
Donev, Ivan, Wei Wang, Tadaaki Yamada, et al.. (2011). Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer. Clinical Cancer Research. 17(8). 2260–2269. 93 indexed citations
20.
Yasumoto, Kazuo, Tadaaki Yamada, Atsuhiro Kawashima, et al.. (2011). The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer. Clinical Cancer Research. 17(11). 3619–3630. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Valerie Odero‐Marah Breakdown of academic impact, for papers by Jelena Urosevic Breakdown of academic impact, for papers by Qiong Zhao Breakdown of academic impact, for papers by Weineng Feng Breakdown of academic impact, for papers by Kuo-Pao Lai Breakdown of academic impact, for papers by Ichiro Nakachi Breakdown of academic impact, for papers by Kaijing Wang Breakdown of academic impact, for papers by Muhammad Alamgeer Breakdown of academic impact, for papers by Shangce Du
Rankless by CCL
2026